Electronic Submission of Adverse Event Reports to FDA FAERS

On This Page

Date: April 4, 2023 – November 7, 2023 Day1: Tue, Apr 04 9:00 a.m. – 03:00 p.m. ET Day2: Tue, Nov 07 9:00 a.m. – 12:00 p.m. ET

The Food and Drug Administration (FDA) is announcing a series of two public meetings entitled “Electronic Submission of Adverse Event Reports to FDA Adverse Event Reporting System (FAERS) using International Council for Harmonisation (ICH) E2B(R3) Standards.” The purpose of these public meetings is to provide the pharmaceutical industry and other interested parties with updated information on the plans, progress, and technical specifications to upgrade electronic submission standards for the premarket and postmarket safety surveillance programs managed by the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation and Research (CBER). These meetings will focus on enhancements to electronic submission of Individual Case Safety Reports (ICSRs) in FAERS using ICH E2B(R3) standards.

Dates and Times:

Past Meetings:

March 25, 2019, from 9:00 a.m. – 4:00 p.m. 
July 17, 2019, from 9:00 a.m. – 4:00 p.m.
February 19, 2020, from 9:00 a.m. – 4:00 p.m.
April 4, 2023, from 9:00 a.m. – 3:00 p.m.
November 7, 2023, from 9:00 a.m. – 12:00 p.m.

Registration:

Registration is closed.

Meeting Materials:

Federal Register Notice for April 4, 2023 and November 7, 2023 meetings.

November 7, 2023 meeting:

April 4, 2023 meeting:

Federal Register Notice for March 25, 2019, July 17, 2019, and February 19, 2020 meetings.

February 19, 2020 meeting:

July 17, 2019 meeting:

March 25, 2019 meeting:

Comments on the Public Meeting:

Please refer to the Federal Register Notice on instructions for submitting either electronic or written comments on this public meeting. We request that comments are submitted before or within 30 days of each public meeting.

Transcripts:

February 19, 2020 (PDF – 828KB)

Wednesday, July 17, 2019 (PDF –  829KB)

Monday, March 25, 2019 (PDF – 1MB)

Tuesday, April 4, 2023 (PDF – 2.8 KB)

Tuesday, November 7, 2023 (PDF – 466 KB)

The transcript will be accessible at Regulations.gov. It may be viewed at the Dockets Management Staff (see ADDRESSES in the Federal Register Notice). A link to the transcript is also available on the internet at FDA Adverse Event Reporting System (FAERS) Electronic Submissions.

Contact Information:

Email: eprompt@fda.hhs.gov

• Content current as of:

  01/11/2024

Source